Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Mar-24 4:38 PM View:  | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 18-Mar-24 | Private Sale | 12,000 | $14.05 | $168,600.00 | (8%) 151.44K to 139.44K | |
| 02-Feb-24 7:12 PM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 31-Jan-24 | Option Exercise | 10,000 | -- | -- | 54% 18.41K to 28.41K | |
| 02-Feb-24 7:07 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-24 | Option Exercise | 6,666 | -- | -- | 4% 148.56K to 155.23K | |
| 02-Feb-24 7:12 PM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 31-Jan-24 | Option Sale | 4,993 | $15.74 | $78,589.80 | (18%) 28.41K to 23.41K | |
| 02-Feb-24 7:05 PM View: | Kim Dong Chief Financial Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-24 | Option Exercise | 3,333 | -- | -- | 14% 23.25K to 26.59K | |
| 02-Feb-24 7:07 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-24 | Option Sale | 3,789 | $15.74 | $59,638.90 | (2%) 155.23K to 151.44K | |
| 05-Sep-23 4:28 PM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 31-Aug-23 | Option Exercise | 8,334 | -- | -- | 60% 13.87K to 22.21K | |
| 05-Sep-23 4:28 PM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 31-Aug-23 | Option Sale | 3,800 | $18.01 | $68,438.00 | (17%) 22.21K to 18.41K | |
| 28-Jul-23 6:06 PM View: | Cohen Fred E Director | Urogen Pharma Ltd. (URGN) | 26-Jul-23 | Grant | 69,339 | $9.54 | $661,494.00 | 100% 0 to 69.34K | (10%) |
| 02-Feb-23 1:04 PM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 31-Jan-23 | Option Sale | 1,636 | $10.12 | $16,556.30 | (11%) 15.51K to 13.87K | |
| 02-Feb-23 1:04 PM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 31-Jan-23 | Option Exercise | 3,333 | -- | -- | 27% 12.18K to 15.51K | |
| 02-Feb-23 3:40 PM View: | Barrett Elizabeth A. Chief Executive Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-23 | Option Exercise | 18,333 | -- | -- | 6% 308.36K to 326.69K | |
| 02-Feb-23 1:02 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-23 | Option Exercise | 3,833 | -- | -- | 3% 146.63K to 150.46K | |
| 02-Feb-23 1:02 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-23 | Option Sale | 1,900 | $10.12 | $19,228.00 | (1%) 150.46K to 148.56K | |
| 23-Jan-23 7:10 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 20-Jan-23 | Option Exercise | 122,677 | $5.00 | $613,385.00 | 512% 23.95K to 146.63K | |
| 02-Nov-22 4:31 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 31-Oct-22 | Option Sale | 258 | $11.85 | $3,057.30 | (1%) 24.21K to 23.95K | |
| 02-Nov-22 4:31 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 31-Oct-22 | Option Exercise | 500 | -- | -- | 2% 23.71K to 24.21K | |
| 25-Oct-22 4:57 PM View: | Nussbaum Ran Director | Urogen Pharma Ltd. (URGN) | 21-Oct-22 | Option Exercise | 47,999 | $5.94 | $285,114.00 | 3% 1.43M to 1.48M | |
| 16-Sep-22 3:13 PM View: | Belldegrun Arie Director | Urogen Pharma Ltd. (URGN) | 14-Sep-22 | Option Exercise | 160,000 | $5.00 | $800,000.00 | 64% 248.69K to 408.69K | |
| 02-Sep-22 11:40 AM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 31-Aug-22 | Option Exercise | 8,333 | -- | -- | 112% 7.45K to 15.78K | |
| 02-Sep-22 11:40 AM View: | Belldegrun Arie Director | Urogen Pharma Ltd. (URGN) | 31-Aug-22 | Option Exercise | 3,241 | $5.00 | $16,205.00 | 1% 245.45K to 248.69K | |
| 02-Sep-22 11:40 AM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 31-Aug-22 | Option Sale | 3,606 | $7.21 | $25,999.30 | (23%) 15.78K to 12.18K | |
| 25-Aug-22 3:25 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 01-Aug-22 | Option Sale | 259 | $7.81 | $2,022.79 | (1%) 23.97K to 23.71K | |
| 25-Aug-22 3:25 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 31-Jul-22 | Option Exercise | 500 | -- | -- | 2% 23.47K to 23.97K | |
| 28-Feb-23 12:21 PM View: | Nussbaum Ran Director | Urogen Pharma Ltd. (URGN) | 16-Jun-22 | Option Exercise | 2,211 | $5.00 | $11,055.00 | < 1% 1.43M to 1.44M | |
| 25-Aug-22 3:25 PM View: | Nussbaum Ran Director | Urogen Pharma Ltd. (URGN) | 06-Jun-22 | Option Exercise | 1,030 | $5.00 | $5,150.00 | < 1% 1.43M to 1.43M | |
| 03-May-22 5:19 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 30-Apr-22 | Option Exercise | 500 | -- | -- | 2% 23.22K to 23.72K | |
| 03-May-22 5:19 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 30-Apr-22 | Option Sale | 254 | $6.62 | $1,681.48 | (1%) 23.72K to 23.47K | |
| 02-Feb-22 4:34 PM View: | Henderson Molly Chief Financial Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-22 | Option Exercise | 666 | -- | -- | 14% 4.91K to 5.58K | |
| 02-Feb-22 4:34 PM View: | Henderson Molly Chief Financial Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-22 | Option Sale | 331 | $7.58 | $2,508.98 | (6%) 5.58K to 5.25K | |
| 02-Feb-22 4:32 PM View: | Barrett Elizabeth A. Chief Executive Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-22 | Option Exercise | 18,333 | -- | -- | 6% 298.22K to 316.55K | |
| 02-Feb-22 4:32 PM View: | Barrett Elizabeth A. Chief Executive Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-22 | Option Sale | 8,195 | $7.58 | $62,118.10 | (3%) 316.55K to 308.36K | |
| 02-Feb-22 4:35 PM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 31-Jan-22 | Option Exercise | 833 | -- | -- | 12% 7.03K to 7.86K | |
| 02-Feb-22 4:35 PM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 31-Jan-22 | Option Sale | 414 | $7.58 | $3,138.12 | (5%) 7.86K to 7.45K | |
| 02-Feb-22 4:33 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-22 | Option Sale | 1,374 | $7.58 | $10,414.90 | (6%) 24.59K to 23.22K | |
| 02-Feb-22 4:33 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 31-Jan-22 | Option Exercise | 2,500 | -- | -- | 11% 22.09K to 24.59K | |
| 28-Jan-22 4:29 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 26-Jan-22 | Option Sale | 111 | $8.09 | $897.99 | (< 1%) 22.21K to 22.09K | |
| 28-Jan-22 4:29 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 26-Jan-22 | Option Exercise | 209 | -- | -- | < 1% 22.0K to 22.21K | |
| 07-Jan-22 8:38 AM View: | Barrett Elizabeth A. Chief Executive Officer | Urogen Pharma Ltd. (URGN) | 04-Jan-22 | Market Option Sale | 46,968 | $9.15 | $429,757.00 | (14%) 345.19K to 298.22K | |
| 07-Jan-22 8:38 AM View: | Barrett Elizabeth A. Chief Executive Officer | Urogen Pharma Ltd. (URGN) | 03-Jan-22 | Option Exercise | 105,689 | -- | -- | 44% 239.5K to 345.19K | |
| 02-Dec-21 1:16 PM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 30-Nov-21 | Option Exercise | 8,333 | -- | -- | 333% 2.5K to 10.83K | |
| 02-Dec-21 1:16 PM View: | Smith Jason Drew General Counsel | Urogen Pharma Ltd. (URGN) | 30-Nov-21 | Market Option Sale | 3,803 | $12.03 | $45,750.10 | (35%) 10.83K to 7.03K | |
| 02-Dec-21 1:15 PM View: | Henderson Molly Chief Financial Officer | Urogen Pharma Ltd. (URGN) | 30-Nov-21 | Option Exercise | 5,000 | -- | -- | 200% 2.5K to 7.5K | |
| 02-Dec-21 1:15 PM View: | Henderson Molly Chief Financial Officer | Urogen Pharma Ltd. (URGN) | 30-Nov-21 | Market Option Sale | 2,587 | $12.03 | $31,121.60 | (34%) 7.5K to 4.91K | |
| 19-Nov-21 3:05 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 18-Nov-21 | Market Purchase | 160 | $13.10 | $2,096.00 | < 1% 21.84K to 22.0K | (4%) |
| 02-Nov-21 3:45 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 01-Nov-21 | Market Option Sale | 258 | $17.16 | $4,427.28 | (1%) 22.09K to 21.84K | |
| 02-Nov-21 3:45 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 31-Oct-21 | Option Exercise | 500 | -- | -- | 2% 21.59K to 22.09K | |
| 28-Oct-21 2:04 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 27-Oct-21 | Market Option Sale | 107 | $16.32 | $1,746.24 | (< 1%) 21.7K to 21.59K | |
| 28-Oct-21 2:04 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 26-Oct-21 | Option Exercise | 208 | -- | -- | < 1% 21.49K to 21.7K | |
| 03-Aug-21 7:07 PM View: | Schoenberg Mark Chief Medical Officer | Urogen Pharma Ltd. (URGN) | 02-Aug-21 | Market Option Sale | 243 | $15.64 | $3,800.52 | (1%) 21.74K to 21.49K |
